Inhibition of deubiquitinating activity of USP14 decreases tyrosine hydroxylase phosphorylated at Ser19 in PC12D cells
Abstract
Tyrosine hydroxylase (TH) is the rate-limiting enzyme in catecholamine biosynthesis, and its stability is a fundamental factor to maintain the level of the catecholamines in cells. However, the intracellular stability determined by the degradation pathway remains unknown. In this study, we investigated the mechanism by which phosphorylation of TH affected the proteasome pathway. The inhibition of proteasomes by MG-132 increased the percentage of TH molecules phosphorylated at their Ser19, Ser31 and/or Ser40 among the total TH proteins to about 70% in PC12D cells over a 24-hr period; although the percentage of phosphorylated TH molecules was about 20% under basal conditions. Moreover, the inhibition of proteasomes by epoxomicin with high specificity increased primarily the quantity of TH molecules phosphorylated at their Ser19. The phosphorylation of Ser19 potentiated Ser40 phosphorylation in cells by a process known as hierarchical phosphorylation. Therefore, the proteasome inhibition might result in an increase in the levels of all 3 phosphorylated TH forms, thus complicating interpretation of data. Conversely, activation of proteasome degradation by IU-1, which is an inhibitor for the deubiquitinating activity of USP14, decreased only the quantity of TH molecules phosphorylated at their Ser19, although it did not decrease that of TH phosphorylated at its Ser31 and Ser40 or that of TH molecules. These results suggest that the phosphorylation of Ser19 in the N-terminal portion of TH is critical as a trigger for the degradation of this enzyme by the ubiquitin-proteasome pathway.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Phosphorylation of the N-terminal TH domain causes proteasomal degradation.
“A publication by Nakashima et al. also showed the proteasomal degradation of the TH protein and evidence that phosphorylation of the N-terminal TH domain causes proteasomal degradation [100,101].”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [101]
Cites
Nagatsu, T., Levitt, M., & Udenfriend, S. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93832-9 · Cited by 2,067 · see citing works
Self-citationLevitt, M., Spector, S., Sjoerdsma, A., & Udenfriend, S. (1965) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27006-9 · Cited by 1,023 · see citing works
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Lee, B., Lee, M. J., Park, S., Oh, D., Elsasser, S., Chen, P., Gartner, C. A., Dimova, N. V., Hanna, J. W., Gygi, S. P., et al. (2010) · Nature · doi:10.1038/nature09299 · Cited by 943 · see citing works
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10403 · Cited by 926 · see citing works
Xu, J., Kao, S., Lee, F. J. S., Song, W., Jin, L., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757 · see citing works
Tyrosine hydroxylase phosphorylation: Regulation and consequences
Dunkley, P. R., Bobrovskaya, L., Graham, M. E., Von Nagy‐Felsobuki, E. I., & Dickson, P. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02797.x · Cited by 455 · see citing works
Isolation of High-Affinity Peptide Antagonists of 14-3-3 Proteins by Phage Display
Wang, B., Yang, H., Liu, Y., Jelı́nek, T., Zhang, L., Ruoslahti, E. I., & Fu, H. (1999) · Biochemistry · doi:10.1021/bi991353h · Cited by 304 · see citing works
Goodwill, K. E., Sabatier, C., Marks, C. B., Raag, R., Fitzpatrick, P. F., & Stevens, R. C. (1997) · Nature Structural Biology · doi:10.1038/nsb0797-578 · Cited by 258 · see citing works
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease
Goldstein, D. S., Sullivan, P., Holmes, C. S., Miller, G. W., Alter, S. P., Strong, R., Mash, D. C., Kopin, I. J., & Sharabi, Y. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12345 · Cited by 206 · see citing works
14‐3‐3η is a novel regulator of parkin ubiquitin ligase
Sato, S., Chiba, T., Sakata, E., Kato, K., Mizuno, Y., Hattori, N., & Tanaka, K. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600774 · Cited by 126 · see citing works
Stimulus-Coupled Interaction of Tyrosine Hydroxylase with 14-3-3 Proteins
Itagaki, C., Isobe, T., Taoka, M., Natsume, T., Nomura, N., Horigome, T., Omata, S., Ichinose, H., Nagatsu, T., Greene, L. A., et al. (1999) · Biochemistry · doi:10.1021/bi9914255 · Cited by 96 · see citing works
Self-citationIMMUNOFLUORESCENT STUDIES ON TYROSINE HYDROXYLASE: APPLICATION FOR ITS AXOPLASMIC TRANSPORT
Nagatsu, I., Kondo, Y., Inagaki, S., Karasawa, N., Kato, T., & Nagatsu, T. (1977) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.10.494 · Cited by 93 · see citing works
Self-citationDifferential Regulation of the Human Tyrosine Hydroxylase Isoforms via Hierarchical Phosphorylation
Lehmann, I. T., Bobrovskaya, L., Gordon, S. L., Dunkley, P. R., & Dickson, P. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512194200 · Cited by 81 · see citing works
Proteasomal dysfunction in sporadic Parkinson's disease
McNaught, K. S. P., Jackson, T., JnoBaptiste, R., Kapustin, A., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s37 · Cited by 73 · see citing works
Verrilli, M. A. L., Pirola, C. J., Pascual, M. M., Dominici, F. P., Turyn, D., & Gironacci, M. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05912.x · Cited by 65 · see citing works
Tank, A. W., Ham, L., & Curella, P. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10389-1 · Cited by 55 · see citing works
Døskeland, A. P., & Flatmark, T. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02808.x · Cited by 53 · see citing works
Nakashima, A., Mori, K., Kaneko, Y. S., Hayashi, N., Nagatsu, T., & Ota, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.020 · Cited by 52 · see citing works
Self-citationDøskeland, A. P., & Flatmark, T. (1996) · Biochemical Journal · doi:10.1042/bj3190941 · Cited by 35 · see citing works
Kawahata, I., Ohtaku, S., Tomioka, Y., Ichinose, H., & Yamakuni, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.125 · Cited by 35 · see citing works
Skjevik, Å. A., Mileni, M., Baumann, A., Halskau, Ø., Teigen, K., Stevens, R. C., & Martı́nez, A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.09.012 · Cited by 33 · see citing works
Shi, X., & Habecker, B. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07539.x · Cited by 31 · see citing works
Kawahata, I., Tokuoka, H., Parvez, H., & Ichinose, H. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0304-z · Cited by 31 · see citing works
Carbajosa, N. A. L., Corradi, G., Verrilli, M. A. L., Guil, M. J., Vatta, M. S., & Gironacci, M. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116597 · Cited by 27 · see citing works
Kojima, M., Oguro, K., Sawabe, K., Iida, Y., Ikeda, R., Yamashita, A., Nakanishi, N., & Hasegawa, H. (2000) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022572 · Cited by 27 · see citing works
Wu, D. K., & Cepko, C. L. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62030863.x · Cited by 23 · see citing works
Intracellular Stability of Tyrosine Hydroxylase
Nakashima, A., Kaneko, Y. S., Kodani, Y., Mori, K., Nagasaki, H., Nagatsu, T., & Ota, A. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00001-4 · Cited by 17 · see citing works
Self-citationNakashima, A., Hayashi, N., Kaneko, Y. S., Mori, K., Egusa, H., Nagatsu, T., & Ota, A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20540 · Cited by 10 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Kawahata, I., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113779 · Cited by 71 · see citing works
- Authors
- Nakashima, A., Ohnuma, S., Kodani, Y., Kaneko, Y. S., Nagasaki, H., Nagatsu, T., & Ota, A.
- Affiliations
- Fujita Health University (JP)
- Corresponding author
- Nakashima, Akira
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 472
- Issue
- 4
- Pages
- 598-602
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2293565794
- Cited by
- 22
- References
- 28
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 2 · 2022: 1 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 2 · 2016: 1
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion)
- PubMed (publishedVersion)
- Funders
- JSPS KAKENHI (25461296)
- Fujita Health University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Keywords
- tyrosine hydroxylase, USP14, deubiquitinase, ubiquitin-proteasome system, protein degradation, proteasome inhibition, catecholamine synthesis, PC12D cells, enzyme stability
- MeSH terms
- Animals, Phosphorylation, Tyrosine 3-Monooxygenase, Signal Transduction, PC12 Cells, Ubiquitin Thiolesterase, Proteasome Endopeptidase Complex, Rats, Ubiquitination, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
